Detalhe da pesquisa
1.
Simultaneous quantification of arctigenin and its glucuronide conjugate in mouse plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
J Sep Sci
; 44(7): 1299-1306, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33387366
2.
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine.
Cancer Sci
; 107(12): 1818-1824, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27685612
3.
TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations.
Mol Cancer Res
; 17(11): 2233-2243, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31467113
4.
Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci.
Cancer Sci
; 99(4): 677-82, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18307533
5.
Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer.
PLoS One
; 13(6): e0198219, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29856804
6.
Provision of a voluntary exercise environment enhances running activity and prevents obesity in Snark-deficient mice.
Am J Physiol Endocrinol Metab
; 296(5): E1013-21, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19276392